Analysts expect $21.8b 2012 Teva revenue

Teva will announce its 2012 business outlook at a live webcast next Wednesday.

Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) today announced that it will host a conference call and live webcast on Wednesday, December 21, 2011 at 8:30 am EST to communicate its 2012 business outlook, followed by a question and answer session. The company did not provide any further details.

The analysts full-year 2012 consensus is $5.67 earnings per share on $21.8 billion revenue. Their fourth quarter 2011 consensus is $1.57 earnings per share on $5.57 billion revenue, and the full-year consensus is $4.95 earnings per share on $18.3 billion revenue.

Factors that will strongly affect Teva's results for the fourth quarter of 2011 and first half of 2012 include a launch of a generic version of Pfizer Inc. (NYSE: PFE; LSE: PFZ) anti-cholesterol drug Lipitor.

Teva's share price has fallen 24% this year, although it has risen 6.5% in the past three months. The share price fell 1% in early trading on the TASE today to NIS 152.90, after rising 0.1% on Nasdaq yesterday to $40.90, giving a market cap of $36 billion.

Published by Globes [online], Israel business news - www.globes-online.com - on December 14, 2011

© Copyright of Globes Publisher Itonut (1983) Ltd. 2011

5 Comments
View comments in rows
Update by email about comments talkback
POST
Comments
Your name
Please insert your name
Content
Hyperlink in a new window Hyperlink Right Left underline italic bold Bulleted List Ordered List Face1 Face2 Face3 Face4 Face5 Face6
Your comment

Thanks
You comment was recieved and soon will be published.
In posting comments, I agree to abide by the Terms of Use
Globes encourages lively and frank debate, but posts that the editors consider merely abusive or otherwise inappropriate will be removed. Report inappropriate content
Thank you for posting your comment, which will be reviewed for publication.
Loading Comments...load
Load more comments
MORE FROM GLOBES
Twitter Facebook Linkedin RSS Newsletters גלובס